-+ 0.00%
-+ 0.00%
-+ 0.00%

Femasys partners with AMI Technologies to enter Israel fertility market

PUBT·04/16/2026 15:46:00
Listen to the news
Femasys partners with AMI Technologies to enter Israel fertility market
  • Femasys entered Israel via strategic partnership with AMI Technologies to commercialize its fertility portfolio.
  • Collaboration positions FemaSeed as first-line infertility treatment in Israel.
  • Market entry adds FemVue for ultrasound diagnosis of tubal-factor infertility.
  • Expansion uses AMI Technologies commercial infrastructure to accelerate adoption across Israeli fertility centers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604160900PRIMZONEFULLFEED9690922) on April 16, 2026, and is solely responsible for the information contained therein.